Ye, Mingxiang
153  results:
Search for persons X
?
3

Efficacy of immunotherapy in patients with oncogene-driven ..:

Chen, Jiayan ; Lu, Wanjun ; Chen, Mo...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
 
?
4

The safety and efficacy of anti-PD-1 inhibitor-based combin..:

Chen, Lu ; Xie, Jingyuan ; Zhu, Meiying...
Translational Cancer Research.  13 (2024)  1 - p. 137-149 , 2024
 
?
7

FBW7-mediated ubiquitination and destruction of PD-1 protei..:

Liu, Jiaxin ; Wei, Lingyun ; Hu, Nan...
Journal for ImmunoTherapy of Cancer.  10 (2022)  9 - p. e005116 , 2022
 
?
9

Response to: Identifying optimal first-line treatment for a..:

Wang, Yimin ; Han, Hedong ; Zhang, Fang...
British Journal of Cancer.  127 (2022)  8 - p. 1383-1384 , 2022
 
?
10

Immune checkpoint inhibitors alone vs immune checkpoint inh..:

Wang, Yimin ; Han, Hedong ; Zhang, Fang...
British Journal of Cancer.  127 (2022)  5 - p. 948-956 , 2022
 
?
13

Targeting the ubiquitination/deubiquitination process to re..:

Liu, Jiaxin ; Cheng, Yicheng ; Zheng, Ming...
Signal Transduction and Targeted Therapy.  6 (2021)  1 - p. , 2021
 
?
14

Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Iden..:

Xu, Qiuli ; Ye, Liang ; Huang, Litang...
OncoTargets and Therapy.  14 (2021)  - p. 2327-2335 , 2021
 
?
15

Treatment with convalescent plasma for COVID‐19 patients in..:

Ye, Mingxiang ; Fu, Dian ; Ren, Yi...
Journal of Medical Virology.  92 (2020)  10 - p. 1890-1901 , 2020
 
1-15